Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Daewoong Pharmaceutical Co Ltd Company Overview 5
Daewoong Pharmaceutical Co Ltd Company Snapshot 5
Daewoong Pharmaceutical Co Ltd Pipeline Products and Ongoing Clinical Trials Overview 5
Daewoong Pharmaceutical Co Ltd – Pipeline Analysis Overview 8
Business Description 8
Daewoong Pharmaceutical Co Ltd – Key Facts 8
Daewoong Pharmaceutical Co Ltd – Major Products and Services 9
Daewoong Pharmaceutical Co Ltd Pipeline Products by Development Stage 11
Daewoong Pharmaceutical Co Ltd Ongoing Clinical Trials by Trial Status 13
Daewoong Pharmaceutical Co Ltd Pipeline Products Overview 15
Donepezil Patch 15
Donepezil Patch Product Overview 15
Iodixanol Contrast Medium 16
Iodixanol Contrast Medium Product Overview 16
Ioversol Contrast Medium 17
Ioversol Contrast Medium Product Overview 17
Mediclore 18
Mediclore Product Overview 18
Mediclore Clinical Trial 19
NOVOSIS – DENT 21
NOVOSIS – DENT Product Overview 21
NOVOSIS – Spinal Fusion 22
NOVOSIS – Spinal Fusion Product Overview 22
NOVOSIS – Spinal Fusion Clinical Trial 23
Daewoong Pharmaceutical Co Ltd – Key Competitors 24
Daewoong Pharmaceutical Co Ltd – Key Employees 25
Daewoong Pharmaceutical Co Ltd – Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Recent Developments 28
Daewoong Pharmaceutical Co Ltd, Recent Developments 28
May 26, 2016: Daewoong Bio ‘UDCA’ passes EDQM (European Directorate for the Quality of Medicines & Healthcare) inspection 28
Apr 06, 2016: Daewoong Pharmaceuticals signs export contract and MOU with Taiwanese and Malaysian pharmaceutical companies 28
Dec 14, 2014: Daewoong Pharmaceutical and Daewoong Bio co-participates in CPhI Worldwide 28
Dec 03, 2014: Daewoong Pharmaceutical’s Ursa completed registration in Georgia 29
Nov 03, 2014: Daewoong Pharmaceutical established Liaoning Research Institute, its local research arm in China 29
Oct 24, 2014: Lee Jong-wook, President of Daewoong Pharmaceutical, was honored with the grand prize in Korea New Drug Award of Pharmaceutical Society of Korea 30
Sep 30, 2014: Daewoong Pharmaceutical rose to the position of undisputed No. 1 leader in terms of pharmaceutical production last year 30
Sep 24, 2014: Daewoong Pharmaceutical was honored with the Prize of the ‘Most Trusted Company in 2014` 31
Mar 18, 2014: Daewoong Pharmaceutical rolls out ‘Easyderm Beauty’, the spot-type wet dressing for treating the skin troubles 32
Dec 30, 2011: New-Concept Medical Equipment ‘Novosis’ Clinical Test Started In Orthopedics In Addition To Dentistry 32
Appendix 33
Methodology 33
About GlobalData 36
Contact Us 36
Disclaimer 36
Daewoong Pharmaceutical Co Ltd Pipeline Products and Ongoing Clinical Trials Overview 5
Daewoong Pharmaceutical Co Ltd Pipeline Products by Equipment Type 6
Daewoong Pharmaceutical Co Ltd Pipeline Products by Indication 7
Daewoong Pharmaceutical Co Ltd Ongoing Clinical Trials by Trial Status 7
Daewoong Pharmaceutical Co Ltd, Key Facts 8
Daewoong Pharmaceutical Co Ltd, Major Products and Services 9
Daewoong Pharmaceutical Co Ltd Number of Pipeline Products by Development Stage 11
Daewoong Pharmaceutical Co Ltd Pipeline Products Summary by Development Stage 12
Daewoong Pharmaceutical Co Ltd Ongoing Clinical Trials by Trial Status 13
Daewoong Pharmaceutical Co Ltd Ongoing Clinical Trials Summary 14
Donepezil Patch - Product Status 15
Donepezil Patch - Product Description 15
Iodixanol Contrast Medium - Product Status 16
Iodixanol Contrast Medium - Product Description 16
Ioversol Contrast Medium - Product Status 17
Ioversol Contrast Medium - Product Description 17
Mediclore - Product Status 18
Mediclore - Product Description 18
Mediclore - A Randomized, Single-blind, Multi-center, Phase III Clinical Trail to Evaluate the Efficacy and Safety of Adhesion Barrier Mediclore Versus no Treatment in Patients with Total Thyroidectomy 19
Mediclore - A Randomized, Single-blind, Multi-center, Phase III Clinical Trail to Evaluate the Efficacy and Safety of Adhesion Barrier Mediclore Versus no Treatment in Patients with Total Thyroidectomy 19
Mediclore - Anti-adhesive Effect and Safety of a Mixed Solid of Poloxamer, Gelatin and Chitosan(Mediclore) after Axillary Dissection for Breast Cancer a Multicenter Double-blinded, Randomized Study 19
Mediclore - Evaluate Anti-adhesive Effect and Safety of a Mixed Solid of Poloxamer, Gelatin and Chitosan (Mediclore) for Intraperitoneal Adhesion in Patient with Gynecological Surgery, a Multicenter Single-blinded, Randomized Study 20
Mediclore - To Evaluate Anti-adhesive Effect and Safety of a Mixed Solid of Poloxamer, Gelatin and Chitosan(Mediclore) after Intrauterine Surgery in Patient with Gynecological Disease, a Multicenter, Randomized, Double- blinded Study 20
NOVOSIS - DENT - Product Status 21
NOVOSIS - DENT - Product Description 21
NOVOSIS - Spinal Fusion - Product Status 22
NOVOSIS - Spinal Fusion - Product Description 22
NOVOSIS - Spinal Fusion - The Clinical Study to Evaluate the Efficacy and Safety of Novosis in Posterolateral Fusion 23
Daewoong Pharmaceutical Co Ltd, Key Employees 25
Daewoong Pharmaceutical Co Ltd, Other Locations 26
Daewoong Pharmaceutical Co Ltd, Subsidiaries 27
Glossary 35
List of Figures
Daewoong Pharmaceutical Co Ltd Pipeline Products by Equipment Type 6
Daewoong Pharmaceutical Co Ltd Pipeline Products by Development Stage 11
Daewoong Pharmaceutical Co Ltd Ongoing Clinical Trials by Trial Status 13